selected scholarly activity
-
academic article
- A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.. Breast Cancer Research and Treatment. 167:485-493. 2018
- Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Research. 19:76. 2017
- Reply to T.J. Powles et al. Journal of Clinical Oncology. 35:2720-2721. 2017
- Changes in expression of the CD200 tolerance-signaling molecule and its receptor (CD200R) by villus trophoblasts during first trimester missed abortion and in chronic histiocytic intervillositis. American Journal of Reproductive Immunology and Microbiology American Journal of Reproductive Immunology. 78:e12665-e12665. 2017
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 35:2062-2081. 2017
- Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists. Current Oncology. 24:138-138. 2017
- Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of Gastrointestinal Oncology. 8:32-38. 2017
- Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine. Hypoxia (Auckl). Volume 5:61-66. 2017
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy. Journal of Clinical Oncology. 34:3914-3920. 2016
- Corrigendum to "The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestation" [J. Reprod. Immunol. 112 (2015) 20-23].. Journal of Reproductive Immunology. 117:89-90. 2016
- Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer. Breast Cancer Research and Treatment. 157:109-116. 2016
- The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks’ gestation. Journal of Reproductive Immunology. 112:20-23. 2015
- The Receptor for the CD200 Tolerance-Signaling Molecule Associated with Successful Pregnancy is Expressed by Early-Stage Breast Cancer Cells in 80% of Patients and by Term Placental Trophoblasts. American Journal of Reproductive Immunology and Microbiology American Journal of Reproductive Immunology. 74:387-391. 2015
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer. British Journal of Cancer. 112:1737-1743. 2015
- Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. Breast Cancer Research and Treatment. 149:293-301. 2015
- Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. Clinical Biochemistry. 47:155-157. 2014
- The CD200-tolerance Signaling Molecule Associated with Pregnancy Success is Present In Patients with Early-stage Breast Cancer but Does not Favor Nodal Metastasis. American Journal of Reproductive Immunology and Microbiology American Journal of Reproductive Immunology. 72:435-439. 2014
- Cardiac and Inflammation Biomarker Profile after Initiation of Adjuvant Trastuzumab Therapy. Clinical Chemistry. 59:327-329. 2013
- Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer. Clinical Oncology Comparative Haematology International. 24:684-696. 2012
- Is Colon Cancer Survival Influenced by Tumor Location?. Journal of Clinical Oncology. 30:1732-1733. 2012
- Systematic Review on Hormone Receptor Testing in Breast Cancer. Applied Immunohistochemistry and Molecular Morphology Applied Immunohistochemistry. 20:214-263. 2012
- Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays—An update from the Canadian society of clinical chemists (CSCC). Clinical Biochemistry. 44:1273-1277. 2011
- Cardiac Troponin Cutoffs: The Importance of Assay Sensitivity and the Patient Population. Journal of Clinical Oncology. 29:e177-e177. 2011
- Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer.. Current Oncology. 16:13-20. 2009
- Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ. 172:1319-1320. 2005
-
conference paper
- Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. 2018
- Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.. Journal of Clinical Oncology. 2017
- The PULSES project: Teaching the vital elements of code status discussions to oncology residents.. Journal of Clinical Oncology. 2017
- Expression of the CD200 tolerance signaling molecule and its receptor (CD200R1) in normal and malignant trophoblasts. Journal of Reproductive Immunology. 30-31. 2015
- Abstract 1154: Serum and urine markers of metabolic dysfunction in colorectal cancer: A pilot study. Cancer Research. 1154-1154. 2015
- Blood and urine markers of metabolic dysfunction in colorectal cancer: a pilot study.. Journal of Clinical Oncology. 2015
- Expression of thyroid hormone receptor alpha (THR alpha) isoforms in triple negative breast cancer (TNBC). Journal of Clinical Oncology. 2015
- Assessment of galectin-3, N-terminal pro-brain natriuretic peptide and inflammatory cytokines in patients with myocardial injury after initiation of adjuvant trastuzumab therapy. Clinical Biochemistry. 1144-1144. 2014
- Prognostic potential of thyroid receptor TR alpha 2 in breast cancer.. Journal of Clinical Oncology. 2014
- Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients.. Journal of Clinical Oncology. 2013
- Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study.. Journal of Clinical Oncology. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). Journal of Clinical Oncology. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC).. Journal of Clinical Oncology. 2012
- NT-proBNP measurement using a multiplex platform in cancer and chest pain populations. Clinical Biochemistry. 1172-1172. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 2011
- Generalizability of results from oncology clinical trials: Toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 6633-6633. 2008
- Tertiary center breast cancer pathology review: Positive impact on patient care. Laboratory Investigation. 30A-30A. 2007
- Tertiary center breast cancer pathology review: Positive impact on patient care. Modern Pathology. 30A-30A. 2007
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases.. Journal of Clinical Oncology. 240S-240S. 2005